This is a preview of subscription content, log in via an institution to check access.
Notes
Innovative Medicines Initiative
References
Wimo A. Global prevalence and economic burden of AD. Internet Document : 20 Nov 2015. Available from: URL: http://www.ipecad.org/
Jonsson L. Strategies and initiatives to reduce dementia - the role of health economics. Internet Document : 20 Nov 2015. Available from: URL: http://www.healtheconomics.se/IPECAD7/1.3_Jonsson.pdf
Marre C. Measuring the cost of non-treatment: a challenge in Alzheimer's Disease. Internet Document : 20 Nov 2015. Available from: URL: http://www.healtheconomics.se/IPECAD7/8.4_Marre.pdf
Leibman C. Reference Model for Economic Evaluation: Industry Perspective. Internet Document : 20 Nov 2015. Available from: URL: http://www.healtheconomics.se/IPECAD7/7.1_Leibman.pdf
Frank L. Capturing and Using Patient-Centered Outcomes. Internet Document : 20 Nov 2015. Available from: URL: http://www.ipecad.org/
Caro JJ. An ACE for Alzheimer's Disease: state of the art modelling. Internet Document : 20 Nov 2015. Available from: URL: http://www.healtheconomics.se/IPECAD7/7.2_Caro.pdf
Rights and permissions
About this article
Cite this article
News from IPECAD. PharmacoEcon Outcomes News 742, 26–27 (2015). https://doi.org/10.1007/s40274-015-2654-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2654-0